Bio-Rad's Q1 Revenues Rise 7 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its first-quarter revenues increased 7 percent year over year, led by its Clinical Diagnostics segment.

The Hercules, Calif.-based firm had total revenues of $485.1 million for the three-month period ended March 31, compared to $454.2 million for Q1 2010. On a currency-neutral basis, its revenues increased 5 percent. Bio-Rad beat analysts' consensus estimate for revenues of $482.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.